Evidence map›Paper›PMID 38264990›Full record

ArticleJournal of proteome research2024

Data-Independent Acquisition Proteomics and N-Terminomics Methods Reveal Alterations in Mitochondrial Function and Metabolism in Ischemic-Reperfused Hearts.

Bridgette Hartley, Wesam Bassiouni, Andrej Roczkowsky, Richard Fahlman, Richard Schulz, Olivier Julien

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bridgette HartleyDepartment of Biochemistry, University of Alberta, Edmonton T6G 2H7, Canada.ORCID 0000-0002-9883-952X
Wesam BassiouniDepartment of Pharmacology, University of Alberta, Edmonton T6G 2S2, Canada.
Andrej RoczkowskyDepartment of Pharmacology, University of Alberta, Edmonton T6G 2S2, Canada.
Richard FahlmanDepartment of Biochemistry, University of Alberta, Edmonton T6G 2H7, Canada.
Richard SchulzDepartment of Pharmacology, University of Alberta, Edmonton T6G 2S2, Canada.
Olivier JulienDepartment of Biochemistry, University of Alberta, Edmonton T6G 2H7, Canada.ORCID 0000-0001-7068-7299
University of Alberta · CA

Funding

CIHR
6 · The paper itself

Abstract

Myocardial ischemia-reperfusion (IR) (stunning) injury triggers changes in the proteome and degradome of the heart. Here, we utilize quantitative proteomics and comprehensive degradomics to investigate the molecular mechanisms of IR injury in isolated rat hearts. The control group underwent aerobic perfusion, while the IR injury group underwent 20 min of ischemia and 30 min of reperfusion to induce a stunning injury. As MMP-2 activation has been shown to contribute to myocardial injury, hearts also underwent IR injury with ARP-100, an MMP-2-preferring inhibitor, to dissect the contribution of MMP-2 to IR injury. Using data-independent acquisition (DIA) and mass spectroscopy, we quantified 4468 proteins in ventricular extracts, whereby 447 proteins showed significant alterations among the three groups. We then used subtiligase-mediated N-terminomic labeling to identify more than a hundred specific cleavage sites. Among these protease substrates, 15 were identified following IR injury. We identified alterations in numerous proteins involved in mitochondrial function and metabolism following IR injury. Our findings provide valuable insights into the biochemical mechanisms of myocardial IR injury, suggesting alterations in reactive oxygen/nitrogen species handling and generation, fatty acid metabolism, mitochondrial function and metabolism, and cardiomyocyte contraction.

Indexed as

Matrix Metalloproteinase 2Myocardial Reperfusion InjuryAnimalsIschemiaMatrix Metalloproteinase InhibitorsMitochondriaMyocardiumProteomicsRatsMatrix Metalloproteinase 2Matrix Metalloproteinase Inhibitorsdata-independent acquisitiondegradomicsintracellular proteaseischemic heart diseasemass spectrometrymatrix metalloproteinaseproteolysis

Identifiers

PMID38264990
PMCPMC10846531
OpenAlexW4391169018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.